GlassScriptPhysician profile
Priya Mary Mathews
NPI 1124398102
$358,123.75
in general payments reported to CMS, 2019-2025
39 companies · $122K in 2025
The $122K reported for 2025 was more than what 99% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $583 · 2021: $35K · 2022: $45K · 2023: $62K · 2024: $94K · 2025: $122K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $187K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Travel and Lodging: $13K · Food and Beverage: $12K · Honoraria: $4,276 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,900 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $186,828.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,017.50 |
| Travel and Lodging | $12,868.20 |
| Food and Beverage | $11,872.87 |
| Honoraria | $4,275.59 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,900.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $73,820.29 | 2020-2025 | Cequa |
| W. L. Gore & Associates, INC. | $71,403.61 | 2024-2025 | Product In Development |
| Johnson & Johnson Surgical Vision, INC. | $49,937.88 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Acuvue |
| Oyster Point Pharma, INC. | $32,376.96 | 2022-2024 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $31,442.37 | 2019-2025 | Tryptyr, Wavelight Refractive Suite, Clareon |
| Abbvie INC. | $27,066.38 | 2022-2025 | |
| Rxsight INC | $16,422.61 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Dompe US, INC. | $15,220.86 | 2020-2025 | Oxervate |
| Alcon Research LLC | $8,901.00 | 2023-2025 | Tryptyr |
| Harrow Eye, LLC | $7,194.95 | 2024-2025 | Vevye, Iheezo |
| Nordic Pharma, INC. | $5,914.54 | 2024-2025 | Lacrifill, Lacrifill |
| Lensar, INC. | $4,550.00 | 2023-2025 | Lensar Laser System |
| Glaukos Corporation | $2,775.89 | 2023-2025 | Ce-Marked Kxla System, Kxl System (Not Refurbished), Kxl1b-Ce-Marked Kxlsystem |
| Tarsus Pharmaceuticals, INC. | $2,515.93 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $2,201.62 | 2022-2025 | Miebo, Xiidra, Scoutpro Osmolarity System |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $1,632.74 | 2021 | |
| Allergan, INC. | $1,452.65 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $1,213.01 | 2023-2025 | Artevo 800, Veracity Surgical, Quatera 700 |
| Johnson & Johnson Vision Care, INC. | $316.21 | 2023-2025 | Acuvue, Tecnis Simplicity, Mentor Siltex Round Spectrum |
| Novartis Pharmaceuticals Corporation | $274.44 | 2020-2023 | |
| Kala Pharmaceuticals, INC. | $201.80 | 2019-2022 | |
| Sight Sciences, INC. | $195.17 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Rayner Intraocular Lenses Limited | $182.08 | 2023-2024 | Rayone Emv, Rayone Spheric, Omidria |
| Carl Zeiss Meditec USA, INC. | $172.66 | 2021-2024 | |
| Ani Pharmaceuticals, INC. | $109.21 | 2025 | Purified Cortrophin Gel |
| Apellis Pharmaceuticals, INC. | $106.49 | 2023 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $84.10 | 2020-2021 | |
| Tearlab Corp | $76.19 | 2021 | |
| Mallinckrodt Hospital Products INC. | $64.99 | 2021-2022 | |
| Glaxosmithkline, LLC. | $51.15 | 2024-2025 | Ojjaara, Blenrep |
| Coopervision INC. | $43.12 | 2025 | Clariti Contact Lens |
| Dutch Ophthalmic, USA | $42.33 | 2024 | Eva, Combined Machine, Tissueblue |
| Ocular Therapeutix, INC. | $35.54 | 2024 | Dextenza |
| Beaver-Visitec International, INC. | $24.73 | 2025 | |
| Akorn Operating Company LLC | $23.77 | 2021 | |
| Horizon Therapeutics Plc | $21.02 | 2021 | |
| Biotissue Holdings INC. | $20.14 | 2021 | |
| Ucb, INC. | $19.35 | 2025 | Bimzelx |
| New World Medical,INC. | $15.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.